The Agency for Healthcare Research and Quality Academy has developed a new resource for healthcare practitioners to aid in treating opioid use disorder (OUD).…
October is the official month for Pregnancy and Infant Loss Awareness, an important time to recognize families and individuals who have suffered such a…
In late September 2019, the U.S. Food and Drug Administration (FDA) approved a new oral treatment for type 2 diabetes. Novo Nordisk’s Rybelsus (semaglutide)…
The U.S. Food and Drug Administration (FDA) has announced Project Orbis, a new initiative from the FDA Oncology Center of Excellence (OCE), which will…
In August 2019, a study was published that investigated the efficacy of educational intervention based on the PRECEDE (Predisposing, Reinforcing and Enabling Constructs in…
In August 2019, a study was published that investigated the efficacy of educational intervention based on the PRECEDE (Predisposing, Reinforcing and Enabling…